Central line-associated bloodstream infection (CLABSI) rates: Achieving the elusive goal of zero

Healthcare Infection

Volumn 19, Issue 2, 2014, Pages 39-41

  McLaws, Mary Louise ^a   Jarvis, William R ^b  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORHEXIDINE;

CATHETER INFECTION; CENTRAL VENOUS CATHETER; HOSPITALIZATION; HUMAN; INFECTION PREVENTION; INTENSIVE CARE; INTENSIVE CARE UNIT; LENGTH OF STAY; REVIEW; RISK FACTOR;

EID: 84901754635     PISSN: 18355617     EISSN: 18355625     Source Type: Journal    
DOI: 10.1071/HI14002     Document Type: Editorial

References (19)

1. CDC Vital Signs: Central line-associated blood stream infections-United States, 2001, 2008, and 2009. MMWR Wkly Rep 2011; 60: 243-8.
2. Cardo D, DennehyPH, Halverson P, FishmanN,KohnM,MurphyCL, et al. Moving toward elimination of healthcare-associated infections: A call to action. Am J Infect Control 2010; 38: 671-5. doi:10.1016/j. ajic.2010.09.001
3. Pronovost PJ, Goeschel CA, Colantuoni E, Watson S, Lubomski JH, Berenholtz SM, et al. Sustaining reductions in catheter related bloodstream infections in Michigan intensive care units: observational study. BMJ 2010; 340: c309. doi:10.1136/bmj.c309
4. Burrell AR, McLaws ML, Pantle A, Murgo M, Herkes R. Aseptic insertion of central lines to reduce bacteraemia. Med J Aust 2011; 194: 583-7.
5. Bion J, Richardson A, Hibbert P, Beer J, McCutcheon M, Cassidy J, et al. The Matching Michigan Collaboration and Writing Committee. 'Matching Michigan': a 2-year stepped interventional programme to minimise central venous catheter-blood stream infections in intensive care units in England. BMJ Qual Saf 2013; 22: 110-23. doi:10.1136/bmjqs-2012-001325
6. Maki DG, Ash SR, Winger RK, Lavin P. A novel antimicrobial and antithrombotic lock solution for hemodialysis catheters: A multicenter, controlled, randomized trial. Crit Care Med 2011; 39: 613-20. doi:10.1097/CCM.0b013e318206b5a2
7. Hockenhull JC, DwanKM,SmithGW,Gamble CL, Boland A, Walley TJ, et al. The clinical effectiveness of central venous catheters treated with anti-infective agents in preventing catheter-related bloodstream infections: a systematic review. Crit Care Med 2009; 37: 702-12. doi:10.1097/CCM.0b013e3181958915
8. Mermel LA, Allon M, Bouza E, Craven DE, Flynn P, O'Grady NP, et al. Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 Update by the Infectious Diseases Society of America. Clin Infect Dis 2009; 49: 1-45. doi:10.1086/599376
9. BarnettAG,Page K, CampbellM,Martin E, Rashleigh-Rolls R, Halton K, et al. The increased risks of death and extra lengths of hospital and ICU stay from hospital-acquired bloodstream infections: a case-control study. BMJ Open 2013; 3: e003587. doi:10.1136/bmjopen-2013-003587
10. Rechner IJ, Lipman J. The costs of caring for patients in a tertiary referral Australian Intensive Care Unit. Anaesth Intensive Care 2005; 33: 477-82. (Pubitemid 41131585
11. Moran JL, Peisach AR, Solomon PJ, Martin J. Cost calculation and prediction in adult intensive care: a ground-up utilization study. Anaesth Intensive Care 2004; 32: 787-97. (Pubitemid 40081334
12. Harnage S. Seven years of zero central-line-associated bloodstream infections. Br J Nurs 2012; 21: S6, S8, S10-2.
13. McLaws ML, Burrell A. Zero risk for central-line-associated bloodstream infection: are we there yet Crit Care Med 2012; 40: 388-93. doi:10.1097/CCM. 0b013e318232e4f3
14. McLaws ML, Berry G. Nonuniform risk for bloodstream infection with increasing central venous catheter-days. Infect Control Hosp Epidemiol 2005; 26: 715-9. doi:10.1086/502608 (Pubitemid 41169742
15. Garland JS, Alex CP, Sevallius JM, Murphy DM, Good MJ, Volberding AM, et al. Cohort study of the pathogenesis and molecular epidemiology of catheter-related bloodstream infection in neonates with peripherally inserted central venous catheters. Infect Control Hosp Epidemiol 2008; 29(3): 243-9. doi:10.1086/526439 (Pubitemid 351269190
16. Ye X, Rupnow M, Bastide P, Lafuma A, Ovington L, Jarvis WR. Economic impact of use of chlorhexidine-impregnated sponge dressing for prevention of central line-associated infections in the United States. Am J Infect Control 2011; 39: 647-54. doi:10.1016/j.ajic.2010.11.008
17. Chernecky CC, Macklin D, Jarvis WR, Joshua TV. Comparison of central line-associated bloodstream infection rates when changing to a zero fluid displacement intravenous needleless connector in acute care settings. Am J Infect Control in press. doi:10.1016/j.ajic.2013.05.023
18. ClimoMW,Yokoe DS, Warren DK, Perl TM, Bolon M, Herwaldt LA, et al. Effect of daily chlorhexidine bathing on hospital-acquired infection. N Engl J Med 2013; 368: 533-42. doi:10.1056/NEJMoa1113849
19. Edwards JR, Peterson KD, Andrus ML, Dudeck MA, Pollack DA, Horan TC. National Healthcare Safety Network (NHSN) Report, data summary for 2006 through 2007, issued November 2008. Am J Infect Control 2008; 36: 609-26. doi:10.1016/j.ajic.2008.08.001